Milestone Pharmaceuticals: Q4 Earnings Insights
Milestone Pharmaceuticals: Q4 Earnings Insights
Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q4 earnings results on Thursday, March 21, 2024 at 07:14 AM.
里程碑製藥（納斯達克股票代碼：MIST）於2024年3月21日星期四上午7點14分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Milestone Pharmaceuticals missed estimated earnings by -3.0%, reporting an EPS of $-0.32 versus an estimate of $-0.31.
里程碑製藥未達到預期收益-3.0％，每股收益爲-0.32美元，而預期爲-0.31美元。
Revenue was down $3.50 million from the same period last year.
收入比去年同期下降了350萬美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.03 which was followed by a 4.0% drop in the share price the next day.
上個季度，該公司的每股收益超過0.03美元，隨後第二天股價下跌了4.0％。
** Listen to the earnings announcement yourself by clicking here. **
** 點擊此處親自收聽業績公告。**
To track all earnings releases for Milestone Pharmaceuticals visit their earnings calendar here.
要跟蹤Milestone Pharmicals發佈的所有業績，請在此處訪問其業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。